233 related articles for article (PubMed ID: 15472203)
1. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin.
Dandona P; Aljada A; Ghanim H; Mohanty P; Tripathy C; Hofmeyer D; Chaudhuri A
J Clin Endocrinol Metab; 2004 Oct; 89(10):5043-7. PubMed ID: 15472203
[TBL] [Abstract][Full Text] [Related]
2. Circulating mononuclear cells in the obese are in a proinflammatory state.
Ghanim H; Aljada A; Hofmeyer D; Syed T; Mohanty P; Dandona P
Circulation; 2004 Sep; 110(12):1564-71. PubMed ID: 15364812
[TBL] [Abstract][Full Text] [Related]
3. Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics.
Ghanim H; Dhindsa S; Aljada A; Chaudhuri A; Viswanathan P; Dandona P
J Clin Endocrinol Metab; 2006 Sep; 91(9):3553-8. PubMed ID: 16804037
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a potent antiinflammatory effect of rosiglitazone.
Mohanty P; Aljada A; Ghanim H; Hofmeyer D; Tripathy D; Syed T; Al-Haddad W; Dhindsa S; Dandona P
J Clin Endocrinol Metab; 2004 Jun; 89(6):2728-35. PubMed ID: 15181049
[TBL] [Abstract][Full Text] [Related]
5. Effect of weight loss on proinflammatory state of mononuclear cells in obese women.
Sheu WH; Chang TM; Lee WJ; Ou HC; Wu CM; Tseng LN; Lang HF; Wu CS; Wan CJ; Lee IT
Obesity (Silver Spring); 2008 May; 16(5):1033-8. PubMed ID: 18356846
[TBL] [Abstract][Full Text] [Related]
6. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
[TBL] [Abstract][Full Text] [Related]
7. Obesity, macrophage migration inhibitory factor, and weight loss.
Church TS; Willis MS; Priest EL; Lamonte MJ; Earnest CP; Wilkinson WJ; Wilson DA; Giroir BP
Int J Obes (Lond); 2005 Jun; 29(6):675-81. PubMed ID: 15795748
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
9. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
[TBL] [Abstract][Full Text] [Related]
10. Effects of body fat reduction on plasma adipocyte fatty acid-binding protein concentration in obese patients with type 1 diabetes mellitus.
Blaha V; Musil F; Smahelova A; Ticha A; Hyspler R; Haluzik M; Lesna J; Sobotka L
Neuro Endocrinol Lett; 2012; 33 Suppl 2():6-12. PubMed ID: 23183502
[TBL] [Abstract][Full Text] [Related]
11. Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Wajcberg E; Bajaj M; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2004 Sep; 89(9):4312-9. PubMed ID: 15356026
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
13. mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action.
Koska J; Stefan N; Dubois S; Trinidad C; Considine RV; Funahashi T; Bunt JC; Ravussin E; Permana PA
Int J Obes (Lond); 2009 Aug; 33(8):842-50. PubMed ID: 19506561
[TBL] [Abstract][Full Text] [Related]
14. Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.
Morin-Papunen L; Rautio K; Ruokonen A; Hedberg P; Puukka M; Tapanainen JS
J Clin Endocrinol Metab; 2003 Oct; 88(10):4649-54. PubMed ID: 14557435
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
Egan JM; Meneilly GS; Habener JF; Elahi D
J Clin Endocrinol Metab; 2002 Aug; 87(8):3768-73. PubMed ID: 12161508
[TBL] [Abstract][Full Text] [Related]
16. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
Robertson DA; Singh BM; Nattrass M
Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
[TBL] [Abstract][Full Text] [Related]
17. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
18. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin.
Abbasi F; Carantoni M; Chen YD; Reaven GM
Diabetes Care; 1998 Aug; 21(8):1301-5. PubMed ID: 9702437
[TBL] [Abstract][Full Text] [Related]
19. Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids.
Iannello S; Camuto M; Cavaleri A; Milazzo P; Pisano MG; Bellomia D; Belfiore F
Diabetes Obes Metab; 2004 Jan; 6(1):8-15. PubMed ID: 14686957
[TBL] [Abstract][Full Text] [Related]
20. Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects.
Ghanim H; Aljada A; Daoud N; Deopurkar R; Chaudhuri A; Dandona P
Diabetologia; 2007 Feb; 50(2):278-85. PubMed ID: 17180352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
